Showing results (2521-2530 of 6,778) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|December 16, 2004
A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitusSherwyn Schwartz, David Hassman, John Shelmet, et al.Clinical Therapeutics|December 16, 2004
Treatment of poor linear growth in a patient with osteogenesis imperfecta type IIIRenee F Robinson, Lynn D Long, John D MahanClinical Therapeutics|March 15, 2005
Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group studyNeil Singla, Annpey Pong, Kenneth Newman, et al.Clinical Therapeutics|March 15, 2005
Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placeboEric Sheldon, Andre Beaulieu, Zorba Paster, et al.Clinical Therapeutics|March 5, 2004
Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adultsLala Mathers Dunbar, Joseph Hassman, Guy TellierClinical Therapeutics|March 5, 2004
Effects of glimepiride on insulin secretion and sensitivity in patients with recently diagnosed type 2 diabetes mellitusMary U Kabadi, Udaya M KabadiClinical Therapeutics|March 5, 2004
A claims analysis comparing citalopram with sertraline as initial pharmacotherapy for a new episode of depression: impact on depression-related treatment chargesTrent P McLaughlin, Michael T Eaddy, Amy N GrudzinskiClinical Therapeutics|March 25, 2004
Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational studyCarmen Turbí, Gabriel Herrero-Beaumont, Juan Carlos Acebes, et al.Clinical Therapeutics|March 25, 2004
A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertensionSheng Kang, Yang Feng Wu, Ning An, et al.Clinical Therapeutics|March 25, 2004
Health care cost of analgesic use in hypertensive patientsC Daniel Mullins, Fadia T Shaya, Louis R Flowers, et al.Pageof 678